Skip to content

Life Science Innovation

Thrives

in the Southeastern United States

Life science innovation that results in successful commercialization of new drugs, therapies, vaccines and technologies that have a value based impact on patient care is not for the faint of heart.

It also takes a sizable, diverse village.

The Southeast United States has all of the resources needed for, and a proven track record of, medtech innovation from its infancy through design, development, testing, regulatory submission, entry to patient care, growth and in some cases very high value acquisitions.

Three examples among hundreds:

3d-printing-healthcare

An Abundance of Medtech Innovation Resources

The southeastern United States has the technical talent, clinicians, patients, connectors, collaborators, quality of life and lifestyle that creates a critical mass for efficient medtech innovation and commercialization.

Why the Southeast for Medtech innovation and Investment?

Boston, San Diego, the Bay Area and other locales where medical technology innovation currently thrives is due in large part to their hefty pools of investors. While the Southeast has work to do to catch up in capital investments in medtech outside of health IT (where Atlanta leads), the volume of investors and the quantity of dollars being invested in medtech innovation is growing and is likely to continue to do so.

investor partnership

How we help

Southeast Life Sciences envisions a world-class ecosystem for life sciences in the southeast. We cultivate, convene, and connect the Southeast entrepreneurial ecosystem to foster life science innovation and investment across the region.

In more detail, we’re the hub, we’re the network that brings all southern life science innovation together in one place:

For Investors & Strategics —

We bring your next, de-risked investable opportunity

For Young Companies —

We introduce you to your investors and potential partners

For Solution Providers —

We bring your next clients

We pair innovators and entrepreneurs with the right investment partners at all stages on the commercialization pathway, acquisition or exit. We provide easy access to qualified experts on life science innovation from concept to commercialization including business strategy, design and development, reimbursement, regulatory, intellectual property, marketing, preclinical and beyond. 

AdvanSE is the organization’s annual flagship conference. 

FROM AN INNOVATOR

Three weeks before the 2015 conference, SweetBio wasn’t even incorporated. Six months later, Innova and MB Venture Partners co-led a significant seed round to support FDA 510(k) clearance of our honey-incorporated advanced wound care product. From that first conference, gaining insights and feedback from Randy Scott, David Huizenga, Chris Hooper, and others helped shape our company. From investor insights to introductions to industry advisors and fellow peers, this event has us coming back year after year.

Kayla Rodriguez Graff, Co-Founder and CEO

— SweetBIo

FROM AN INVESTOR

“By attending AdvanSE, I get to meet some of the leading entrepreneurs and interesting companies in the Southeast.  AdvanSE offers exclusive opportunities to network with other investors and strategics and is the one-stop shop for innovation in the region.”

Kyp Sirinakis, Co-Founder and Managing Partner

— Epidarex Capital

FROM AN INNOVATOR

“This conference provided us an incredible opportunity to connect with a large number of diverse life science professionals, which is not always easy to do for life science companies headquartered in the heartland. The exposure to investors and collaborators was instrumental to our early stage company.”

Vance Clement, CEO

— Lineus Medical, Pitchrounds participant 2019 and 2021

FROM AN INVESTOR

“HealthQuest partners are active participants in reviewing early stage businesses and investing across the healthcare spectrum – including medical devices, healthcare information technologies, diagnostics, novel delivery systems that improve patient outcomes and reduce costs. We find PitchRounds an early preview of companies that are rapidly growing and might become opportunities for investing as they seek growth capital.”

Tom Callaway, Venture Partner

— HealthQuest Capital

HOVER TO PAUSE

Invested in Innovation

1
Company Presenters
1
Funding Transactions
$ 1 B
Dollars Raised
1
Distinct Investors

Connect With Us

If you would like to know more about the state of life science innovation in the Southeast, we encourage you to subscribe to our monthly newsletter (below) and follow us on Twitter and LinkedIn.

If you would like to take a deeper dive, contact SLS Executive Director Jason Rupp